Company profile: Julius Clinical
1.1 - Company Overview
Company description
- Provider of clinical trial services offering full-service or functional support across CNS diseases (ALS, dementia, Parkinson’s, epilepsy, hearing loss), cardio-metabolic and renal, and infectious diseases & vaccines. Leverages Brain Clinical and scientific site networks to optimize protocols and streamline trials. Provides CRO from early to post-registration, real-world data, and SMO with large-scale recruitment and site support.
Products and services
- CRO Services: Julius Clinical orchestrates full-service clinical trial management across early phase to post-registration, incorporating real-world data projects to enrich evidence and streamline oversight
- CNS Diseases: Julius Clinical conducts network-driven trials in ALS, Dementia, Parkinson’s Disease, Epilepsy, and Hearing Loss, leveraging the proprietary Brain Clinical site network for targeted enrollment and execution
- Cardio-Metabolic and Renal Diseases: Julius Clinical manages scientifically-networked trials for cardio-metabolic and kidney indications, utilizing site networks and collaborations to generate patient data with coordinated oversight and consistent processes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Julius Clinical
Oncodesign Services
HQ: France
Website
- Description: Provider of CRO drug discovery and preclinical services from target identification to IND filing in oncology, inflammation and infectious diseases. Services span small-molecule discovery (PROTAC, molecular radiotherapy; hit finding, lead optimization, candidate generation), preclinical proof of concept (oncology, inflammation, COVID-19; pharmacology imaging, DMPK, microbiome), IND support (toxicology, CMC), bioanalysis, in vitro assays, and pharmaco-imaging.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oncodesign Services company profile →
Bioqual
HQ: United States
Website
- Description: Provider of AAALAC-accredited pre-clinical research and model development services, offering in vivo studies in small and large animal models, in vitro services (sample processing, virus stock generation, and assays including virus neutralization, hemagglutination inhibition, and quantitative PCR), vaccine evaluation (therapeutics and microbicides), drug therapy testing, and consulting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioqual company profile →
Gentronix
HQ: United Kingdom
Website
- Description: Provider of regulatory genotoxicity studies (GLP Ames, mouse lymphoma, in vitro micronucleus), predictive genotoxicity screening to detect liability early, skin toxicology assays for corrosion, irritation and sensitisation, and flow cytometry services. Includes Ames MPF/II and 24-well Agar formats requiring low test item amounts. Supports drug development and chemicals in cosmetics, personal care, and other chemistry driven industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentronix company profile →
Galenicum
HQ: Spain
Website
- Description: Provider of pharmaceutical products and services, including R&D, regulatory affairs, manufacturing, licensing, and global supply across technologies from injectables to oral solids and nasal sprays. Operates a facility near Madrid producing over 50 million packs annually, trades APIs, and markets Vitae bioequivalent medicines and Galenicum Derma specialty dermatology products; applies QbD standards in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Galenicum company profile →
Lightcast
HQ: United Kingdom
Website
- Description: Provider of a droplet-based microfluidics and oEWOD platform for parallel and sequential single-cell assays, live-cell recovery for downstream applications, and multi-step workflows that streamline lead identification and optimization in drug discovery, supporting basic and translational research on cell-to-cell communication, immune function, and the impact of CRISPR edits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lightcast company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Julius Clinical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Julius Clinical
2.2 - Growth funds investing in similar companies to Julius Clinical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Julius Clinical
4.2 - Public trading comparable groups for Julius Clinical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →